{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:16:21Z","timestamp":1787584581738,"version":"build-2736575974"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,11]]},"DOI":"10.7759\/cureus.103408","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T11:41:56Z","timestamp":1770810116000},"source":"Crossref","is-referenced-by-count":2,"title":["Clinical Characteristics and Predictors of Hypokalemia in Patients Receiving Piperacillin\/Tazobactam: A Retrospective Observational Audit"],"prefix":"10.7759","author":[{"given":"Taonga","family":"Gogo-Peters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musa Usman","family":"Nahuche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somtochukwu","family":"Okafor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199808133390707","article-title":"Hypokalemia","volume":"339","author":"Gennari FJ","year":"1998","unstructured":"Gennari FJ. Hypokalemia. N Engl J Med. 1998, 339:451-8. 10.1056\/NEJM199808133390707","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(05)70536-8","article-title":"Hypokalemia and hyperkalemia","volume":"81","author":"Mandal AK","year":"1997","unstructured":"Mandal AK. Hypokalemia and hyperkalemia. Med Clin North Am. 1997, 81:611-39. 10.1016\/S0025-7125(05)70536-8","journal-title":"Med Clin North Am"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1248\/yakushi.19-00143","article-title":"Incidence and risk factors of hypokalemia in tazobactam\/piperacillin-administered patients [Article in Japanese]","volume":"139","author":"Kuramoto H","year":"2019","unstructured":"Kuramoto H, Masago S, Kashiwagi Y, Maeda M. Incidence and risk factors of hypokalemia in tazobactam\/piperacillin-administered patients [Article in Japanese]. Yakugaku Zasshi. 2019, 139:1591-600. 10.1248\/yakushi.19-00143","journal-title":"Yakugaku Zasshi"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11081138","article-title":"Incidence and determinants of piperacillin\/tazobactam-associated hypokalemia: a retrospective study","volume":"11","author":"Seo H","year":"2022","unstructured":"Seo H, Kim E. Incidence and determinants of piperacillin\/tazobactam-associated hypokalemia: a retrospective study. Antibiotics (Basel). 2022, 11:1138. 10.3390\/antibiotics11081138","journal-title":"Antibiotics (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.84986","article-title":"Piperacillin-tazobactam-induced hypokalemia and metabolic alkalosis","volume":"43","author":"Zaki SA","year":"2011","unstructured":"Zaki SA, Lad V. Piperacillin-tazobactam-induced hypokalemia and metabolic alkalosis. Indian J Pharmacol. 2011, 43:609-10. 10.4103\/0253-7613.84986","journal-title":"Indian J Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2009.17","article-title":"Fluid, electrolyte and acid-base disorders associated with antibiotic therapy","volume":"5","author":"Zietse R","year":"2009","unstructured":"Zietse R, Zoutendijk R, Hoorn EJ. Fluid, electrolyte and acid-base disorders associated with antibiotic therapy. Nat Rev Nephrol. 2009, 5:193-202. 10.1038\/nrneph.2009.17","journal-title":"Nat Rev Nephrol"},{"key":"ref7","article-title":"Electrolytes imbalance: a rare side effect of piperacillin\/ tazobactam therapy","volume":"20","author":"Hussain S","year":"2010","unstructured":"Hussain S, Syed S, Baloch K. Electrolytes imbalance: a rare side effect of piperacillin\/ tazobactam therapy. J Coll Physicians Surg Pak. 2010, 20:419-20.","journal-title":"J Coll Physicians Surg Pak"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.17-3-263","article-title":"Hyponatraemia - presentations and management","volume":"17","author":"Dineen R","year":"2017","unstructured":"Dineen R, Thompson CJ, Sherlock M. Hyponatraemia - presentations and management. Clin Med (Lond). 2017, 17:263-9. 10.7861\/clinmedicine.17-3-263","journal-title":"Clin Med (Lond)"},{"key":"ref9","unstructured":"Guidelines for preparing core clinical-safety information on drugs. (1999). https.\/\/cioms.ch\/wp-content\/uploads\/2018\/03\/Guidelines-for-Preparing-Core-Clinical-Safety-Info-Drugs-Report-of-CIOMS-...."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/447694-clinical-characteristics-and-predictors-of-hypokalemia-in-patients-receiving-piperacillintazobactam-a-retrospective-observational-audit","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T11:41:57Z","timestamp":1770810117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/447694-clinical-characteristics-and-predictors-of-hypokalemia-in-patients-receiving-piperacillintazobactam-a-retrospective-observational-audit"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.103408","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,11]]}}}